Christopher E. Helt
Impact in
-
- Carcinogens and Genotoxicity Assessment
- Cancer, Hypoxia, and Metabolism
-
- Cancer-related Molecular Pathways
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 7
- PARP inhibition in cancer therapy 2
-
- DNA Repair Mechanisms 4
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Co-authors
- Peter C. Keng (7 shared papers)Michael A. O’Reilly (6 shared papers)Robert A. Bambara (4 shared papers)William A. Cliby (1 shared paper)Wensheng Wang (1 shared paper)Sandra M. Schneider (1 shared paper)Guang Gao (1 shared paper)Dirk Bohmann (1 shared paper)
- Journals
- American Journal of Physiology-Lung Cellular and Molecular Physiology (2 papers)Biochemical and Biophysical Research Communications (1 paper)Toxicological Sciences (1 paper)Journal of Biological Chemistry (1 paper)Free Radical Biology and Medicine (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Christopher E. Helt
10 papers receiving 568 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 126
- Oncology 177
- Molecular Biology 405
- Aging 6
- Biotechnology 27
Countries citing papers authored by Christopher E. Helt
This map shows the geographic impact of Christopher E. Helt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Helt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Helt more than expected).
Fields of papers citing papers by Christopher E. Helt
This network shows the impact of papers produced by Christopher E. Helt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Helt. The network helps show where Christopher E. Helt may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher E. Helt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 157 | |
| 2 | 2004 | 109 | |
| 3 | 2001 | 77 | |
| 4 | 2005 | 69 | |
| 5 | 2001 | 42 | |
| 6 | 2013 | 39 | |
| 7 | 2004 | 32 | |
| 8 | 2005 | 17 | |
| 9 | 2006 | 15 | |
| 10 | 2006 | 14 |
About Christopher E. Helt
Christopher E. Helt is a scholar working on Oncology, Molecular Biology, Cancer Research, Biotechnology and Epidemiology, having authored 10 papers that have together received 571 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), DNA Repair Mechanisms (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), PARP inhibition in cancer therapy (2 papers), Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (2 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (126 citations), Oncology (177 citations), Molecular Biology (405 citations), Aging (6 citations) and Biotechnology (27 citations). Christopher E. Helt has collaborated with scholars based in United States and Germany. Frequent co-authors include Peter C. Keng, Michael A. O’Reilly, Robert A. Bambara, William A. Cliby, Wensheng Wang, Sandra M. Schneider, Guang Gao, Dirk Bohmann, Carsten Weiß and Jiyong Zhao. Their work appears in journals such as American Journal of Physiology-Lung Cellular and Molecular Physiology, Biochemical and Biophysical Research Communications, Toxicological Sciences, Journal of Biological Chemistry and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.